Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T19:10:25.786Z.
Calculation as of: 2026-10-06T19:10:25.786Z.
Quote observation: 2026-10-06T19:07:06.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e8c4723d74b6f0443862f85907ca9030ea6941843cb736177163438a313e1ca1
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Market Cap
$140.49M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$137.57M
Free Cash Flow Yield
0.19%
TTM Avg
0.11%
3Y Avg
0.11%
5Y Avg
0.11%
Market Cap
$137.53M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$141.48M
Free Cash Flow Yield
N/A
TTM Avg
3.59%
3Y Avg
3.59%
5Y Avg
3.59%
Market Cap
$136.92M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$142.96M
Free Cash Flow Yield
88.03%
TTM Avg
20.53%
3Y Avg
20.53%
5Y Avg
20.53%
Market Cap
$143.60M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alpha Cognition Inc (ACOG) | $139.39M | N/A | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $140.49M | N/A | N/A | N/A | N/A |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.57M | 0.19% | 0.11% | 0.11% | 0.11% |
| Atrium Therapeutics, Inc. (RNA)vs › | $137.53M | N/A | N/A | N/A | N/A |
| Sutro Biopharma, Inc. (STRO)vs › | $141.48M | N/A | 3.59% | 3.59% | 3.59% |
| Organigram Global Inc. (OGI)vs › | $136.92M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $142.96M | 88.03% | 20.53% | 20.53% | 20.53% |
| Protara Therapeutics, Inc. (TARA)vs › | $143.60M | N/A | N/A | N/A | N/A |
| Nyxoah S.A. (NYXH)vs › | $143.60M | N/A | N/A | N/A | N/A |
| Korsana Biosciences, Inc. (KRSA)vs › | $144.93M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
